Accueil>>Signaling Pathways>> Microbiology & Virology>> HIV>>MS417 (GTPL7512)

MS417 (GTPL7512) (Synonyms: GTPL7512)

Catalog No.GC31881

MS417 (GTPL7512) est un inhibiteur sélectif de BRD4 spécifique À BET, se lie À BRD4-BD1 et BRD4-BD2 avec des IC50 de 30, 46 nM et des Kd de 36,1, 25,4 nM, respectivement, avec une faible sélectivité À CBP BRD (IC50, 32,7 μ ;M).

Products are for research use only. Not for human use. We do not sell to patients.

MS417 (GTPL7512) Chemical Structure

Cas No.: 916489-36-6

Taille Prix Stock Qté
10mM (in 1mL DMSO)
89,00 $US
En stock
5mg
81,00 $US
En stock
10mg
126,00 $US
En stock
50mg
333,00 $US
En stock
100mg
558,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MS417 is a BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 μM).

MS417 is a BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively, with less selectivity at CBP BrD (IC50, 32.7 μM). MS417 effectively blocks BRD4 binding to NF-κB, almost completely suppresses TNFα-induced NF-κB transcription activation in human embryonic kidney 293T cells at 1 μM and also reduces NF-κB p65 acetylation in the HIV-infected RTECs. MS417 (1 μM) modulation of gene transcription in HIV-infected human primary renal tubular epithelial cells. In addition, MS417 suppresses NF-κB-targeted cytokines and chemokines[1].

MS417 (0.08 mg/kg) markedly improves renal function, reduces proteinuria and decreases glomerulosclerosis, tubular injury, and infiltration of inflammatory cells in the kidney of Tg26 mice[1].

[1]. Zhang G, et al. Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem. 2012 Aug 17;287(34):28840-51.

Avis

Review for MS417 (GTPL7512)

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MS417 (GTPL7512)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.